Blood-Brain Barrier in Drug Discovery

Blood-Brain Barrier in Drug Discovery Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs

Hardback (27 Jan 2015)

  • $181.44
Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7 days

Publisher's Synopsis

Focused on central nervous system (CNS) drug discovery efforts, this book educates drug researchers about the blood-brain barrier (BBB) so they can affect important improvements in one of the most significant - and most challenging - areas of drug discovery.

 Written by world experts to provide practical solutions to increase brain penetration or minimize CNS side-effects
 Reviews state-of-the-art in silico, in vitro, and in vivo tools to assess brain penetration and advanced CNS drug delivery strategies
 Covers BBB physiology, medicinal chemistry design principles, free drug hypothesis for the BBB, and transport mechanisms including passive diffusion, uptake/efflux transporters, and receptor-mediated processes
 Highlights the advances in modelling BBB pharmacokinetics and dynamics relationships (PK/PD) and physiologically-based pharmacokinetics (PBPK)
 Discusses case studies of successful CNS and non-CNS drugs, lessons learned and paths to the market

Book information

ISBN: 9781118788356
Publisher: Wiley
Imprint: John Wiley & Sons, Inc.
Pub date:
DEWEY: 615.78
DEWEY edition: 23
Language: English
Number of pages: xiv, 586
Weight: 946g
Height: 165mm
Width: 242mm
Spine width: 35mm